Skip to main content

Featured

Interviews
10/13/2019
David Prologo, MD, presented on cryoneurolysis at the Symposium on Clinical Interventional Oncology (CIO) in Miami, Florida. Dr. Prologo is an interventional radiologist from Emory University in Atlanta, Georgia, and his presentation identified …
News
10/12/2019
Nine faculty members presented in a session entitled “Outside Your IO Comfort Zone: Learning from Our Saves and Complications”, sharing both catastrophic complication and miraculous save cases. 
News
10/12/2019
Saturday, October 12, 2019 (Miami, FL): Today the Symposium on Clinical Interventional Oncology (CIO) experienced an educational first-in-technology presentation by Course Co-Director Ziv Haskal, MD, Professor/Fellowship Director, Interventional…
News
10/12/2019
The Symposium on Clinical Interventional Oncology featured a morning session focusing on therapeutic areas that are positioned to grow.
News
10/11/2019
Friday, October 11, 2019 (Miami, FL) — Providing attendees with practical take-home tips for the treatment of liver cancer was the purpose of the final session on day one of the Symposium on Clinical Interventional Oncology (CIO).
News
10/11/2019
As liver therapy continues to rapidly evolve, the Symposium on Clinical Interventional Oncology featured a morning session updating attendees on changes that have occurred in recent months.
News
10/11/2019
Areas ranging from immuno-oncology to artificial intelligence are poised to shape the future of care. The first day of the Symposium on Clinical Interventional Oncology featured a session focusing on emerging trends in interventional oncology. 
News
10/11/2019
Friday, October 11, 2019 (Miami, FL) — The first day of the Symposium on Clinical Interventional Oncology (CIO) explored radioembolization using Y90 in detail.
News
10/10/2019
Addressing the needs of physicians new to the interventional oncology (IO) field, the Symposium on Clinical Interventional Oncology (CIO) opened its first day with a pre-conference session focusing on IO fundamentals.
Interviews
10/03/2019
Tim McClure, MD, discussed biopsy and ablation staging, circumstances in which renal mass biopsy is necessary, and recommendations from guidelines.
Back to Top